Skip to main content

Sacklers Reach $6 Billion Deal Over Purdue Pharma's OxyContin Lawsuits

The new deal would restructure the company into a new entity called Knoa Pharma that a public board controls. Family members are relinquishing ownership and must, finally, apologize.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.